What We're Reading: Medicare Pay Cuts; Health Insurers Covet Sicker Patients; Misbranded Weight Loss Drug Sales

Part of the recent Medicare reimbursement cuts could be addressed in a spending package next month; Medicaid/Medicare dual eligibles are expected to generate big profits for health insurers; FDA sent warning letters to online vendors selling unapproved and misbranded versions of semaglutide and tirzepatide.

Related Keywords

Indiana ,United States ,Larry Bucshon ,Health Insurers Are Suddenly Coveting Sicker Patients ,Physicians Lobby Congress On Medicare Pay ,Physicians Lobby Congress ,Medicare Pay ,What We X27 Re Reading ,Medicare Reimbursement Cuts ,Medicaid ,Medicare ,Ozempic ,Mounjaro ,Zepbound ,Wegovy ,Semaglutide ,Tirzepatide ,Misbranded Drugs ,Fda ,Congress ,